Akt isoforms and glucose homeostasis - the leptin connection

Trends in Endocrinology and Metabolism

Volumn 22, Issue 2, 2011, Pages 66-73

  Hay, Nissim ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; LEPTIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE AKT3; PROTEIN KINASE B; PROTEIN KINASE B BETA; PROTEIN KINASE B INHIBITOR; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C RECEPTOR; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; BONE DEVELOPMENT; CELL DIFFERENTIATION; DIABETES MELLITUS; DIABETOGENESIS; DISEASE SEVERITY; EMBRYO DEVELOPMENT; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HAPLOTYPE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIPOATROPHY MEDIATED DIABETES; LIPODYSTROPHY; MUSCLE ATROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKIN;

ANIMALS; DIABETES MELLITUS; GLUCOSE; HOMEOSTASIS; INSULIN; INSULIN RESISTANCE; ISOENZYMES; LEPTIN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 79251645858     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2010.09.003     Document Type: Review

References (74)

1. Kandel E.S., Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. 1999, 253:210-229.
2. Teleman A.A. Molecular mechanisms of metabolic regulation by insulin in Drosophila. Biochem. J. 2009, 425:13-26.
3. Panowski S.H., Dillin A. Signals of youth: endocrine regulation of aging in Caenorhabditis elegans. Trends Endocrinol. Metab. 2009, 20:259-264.
4. Peng X.D., et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 2003, 17:1352-1365.
5. Mauvais-Jarvis F., et al. Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance. Clin. Endocrinol. (Oxf.) 2002, 57:1-9.
6. Withers D.J., et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998, 391:900-904.
7. Cho H., et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001, 292:1728-1731.
8. Garofalo R.S., et al. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J. Clin. Invest. 2003, 112:197-208.
9. George S., et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 2004, 304:1325-1328.
10. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 2002, 296:1655-1657.
11. Bhaskar P.T., Hay N. The two TORCs and Akt. Dev. Cell 2007, 12:487-502.
12. Parsons R., Simpson L. PTEN and cancer. Methods Mol. Biol. 2003, 222:147-166.
13. Huang H., Tindall D.J. Dynamic FoxO transcription factors. J. Cell Sci. 2007, 120:2479-2487.
14. Chen W.S., et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 2001, 15:2203-2208.
15. Cho H., et al. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 2001, 276:38349-38352.
16. Tschopp O., et al. Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis. Development 2005, 132:2943-2954.
17. Easton R.M., et al. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol. Cell Biol. 2005, 25:1869-1878.
18. Chen W.S., et al. Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. Mol. Cell Biol. 2009, 29:3151-3162.
19. Buzzi F., et al. Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass. Mol. Cell Biol. 2010, 30:601-612.
20. Cantley J., et al. Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice. Diabetologia 2007, 50:1248-1256.
21. Yang Z.Z., et al. Dosage-dependent effects of Akt1/protein kinase Balpha (PKBalpha) and Akt3/PKBgamma on thymus, skin, and cardiovascular and nervous system development in mice. Mol. Cell Biol. 2005, 25:10407-10418.
22. Dummler B., et al. Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies. Mol. Cell Biol. 2006, 26:8042-8051.
23. Brachmann S.M., et al. Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice. Mol. Cell Biol. 2005, 25:1596-1607.
24. Elghazi L., Bernal-Mizrachi E. Akt and PTEN: beta-cell mass and pancreas plasticity. Trends Endocrinol. Metab. 2009, 20:243-251.
25. Kushner J.A., et al. Phosphatase and tensin homolog regulation of islet growth and glucose homeostasis. J. Biol. Chem. 2005, 280:39388-39393.
26. Alessi D.R., et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 1997, 7:261-269.
27. Bayascas J.R., et al. Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance. Mol. Cell Biol. 2008, 28:3258-3272.
28. Leibiger I.B., et al. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol. Cell 1998, 1:933-938.
29. Leibiger I.B., et al. Insulin feedback action on pancreatic beta-cell function. FEBS Lett. 2002, 532:1-6.
30. Shigeyama Y., et al. Biphasic response of pancreatic beta-cell mass to ablation of tuberous sclerosis complex 2 in mice. Mol. Cell Biol. 2008, 28:2971-2979.
31. Rachdi L., et al. Disruption of Tsc2 in pancreatic beta cells induces beta cell mass expansion and improved glucose tolerance in a TORC1-dependent manner. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9250-9255.
32. Bernal-Mizrachi E., et al. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J. Clin. Invest. 2004, 114:928-936.
33. Bernal-Mizrachi E., et al. Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J. Clin. Invest. 2001, 108:1631-1638.
34. Tuttle R.L., et al. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat. Med. 2001, 7:1133-1137.
35. Gorden P., Gavrilova O. The clinical uses of leptin. Curr. Opin. Pharmacol. 2003, 3:655-659.
36. Leavens K.F., et al. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab. 2009, 10:405-418.
37. Laustsen P.G., et al. Lipoatrophic diabetes in Irs1(-/-)/Irs3(-/-) double knockout mice. Genes Dev. 2002, 16:3213-3222.
38. Pelleymounter M.A., et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269:540-543.
39. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
40. Harris R.B., et al. A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. Endocrinology 1998, 139:8-19.
41. Rossetti L., et al. Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J. Biol. Chem. 1997, 272:27758-27763.
42. O'Doherty R.M., et al. Sparing effect of leptin on liver glycogen stores in rats during the fed-to-fasted transition. Am. J. Physiol. 1999, 277:E544-550.
43. Yu X., et al. Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14070-14075.
44. Wang M.Y., et al. Leptin therapy in insulin-deficient type I diabetes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:4813-4819.
45. Hedbacker K., et al. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab. 2010, 11:11-22.
46. Cohen S.E., et al. High circulating leptin receptors with normal leptin sensitivity in liver-specific insulin receptor knock-out (LIRKO) mice. J. Biol. Chem. 2007, 282:23672-23678.
47. Dong X., et al. Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. J. Clin. Invest. 2006, 116:101-114.
48. Taniguchi C.M., et al. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta. Cell Metab. 2006, 3:343-353.
49. Gross D.N., et al. The role of FoxO in the regulation of metabolism. Oncogene 2008, 27:2320-2336.
50. Li X., et al. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature 2007, 447:1012-1016.
51. Inoue H., et al. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat. Med. 2004, 10:168-174.
52. Buettner C., et al. Critical role of STAT3 in leptin's metabolic actions. Cell Metab. 2006, 4:49-60.
53. Asilmaz E., et al. Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J. Clin. Invest. 2004, 113:414-424.
54. Crouthamel M.C., et al. Mechanism and management of AKT inhibitor-induced hyperglycemia. Clin. Cancer Res. 2009, 15:217-225.
55. Bae S.S., et al. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J. Biol. Chem. 2003, 278:49530-49536.
56. Summers S.A., et al. Differentiation-dependent suppression of platelet-derived growth factor signaling in cultured adipocytes. J. Biol. Chem. 1999, 274:23858-23867.
57. Zhang H.H., et al. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS One 2009, 4:e6189.
58. Le Bacquer O., et al. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J. Clin. Invest. 2007, 117:387-396.
59. Carnevalli L.S., et al. S6K1 plays a critical role in early adipocyte differentiation. Dev. Cell 2010, 18:763-774.
60. Accili D., Arden K.C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004, 117:421-426.
61. Nakae J., et al. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 2002, 32:245-253.
62. Kitamura T., et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J. Clin. Invest. 2002, 110:1839-1847.
63. Laplante M., Sabatini D.M. mTOR signaling at a glance. J. Cell Sci. 2009, 122:3589-3594.
64. Hay N., Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004, 18:1926-1945.
65. Inoki K., et al. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003, 115:577-590.
66. Gwinn D.M., et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 2008, 30:214-226.
67. Hahn-Windgassen A., et al. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J. Biol. Chem. 2005, 280:32081-32089.
68. El-Chaar D., et al. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1. Int. J. Obes. Relat. Metab. Disord. 2004, 28:191-198.
69. Polak P., et al. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab. 2008, 8:399-410.
70. Du K., et al. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003, 300:1574-1577.
71. Cheng K.K., et al. APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. Cell Metab. 2009, 9:417-427.
72. Hirosumi J., et al. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
73. Decker S.J., Saltiel A.R. Staying in SHIP shape. Nat. Med. 2005, 11:123-124.
74. Brognard J., Newton A.C. PHLiPPing the switch on Akt and protein kinase C signaling. Trends Endocrinol. Metab. 2008, 19:223-230.